Ginseng Cambium Stem Cell Composition for AIDS Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapeutic agents for AIDS, such as antiretroviral drugs, often come with severe side effects and do not provide complete therapeutic effects, leading to the need for novel medicaments that can effectively prevent and treat the condition with minimized adverse effects.
Innovation Solution
A composition comprising a cell line derived from the cambium of Panax ginseng, including wild ginseng, which is in an innately undifferentiated, homogeneous, and morphologically characterized by multiple vacuoles, is used as an active ingredient to enhance T-cell count and inhibit HIV proliferation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional anti-HIV agents (AZT, ddI, ddC) are used, then HIV infection is targeted, but severe adverse side effects occur and complete therapeutic effects are not achieved
Solution Approach 1:
The invention changes the chemical composition parameter by using plant stem cell lines (Panax ginseng, Panax notoginseng, Angelica sinensis) instead of synthetic anti-HIV drugs. This parameter change results in a different mechanism of action that enhances immune function without the severe side effects associated with conventional agents like AZT, ddI, and ddC.
Solution Approach 2:
The invention uses natural plant-based substances that are biodegradable and metabolized naturally by the body, replacing long-lasting synthetic drugs with accumulation of harmful effects. The plant stem cell lines and their extracts are processed and eliminated through natural metabolic pathways, avoiding the accumulation of toxic metabolites.
2Reliability
If protease inhibitors are used for long-term administration, then HIV replication is interrupted, but tolerant cell lines emerge and serious problems occur
Solution Approach 1:
The invention uses plant stem cell lines and their metabolites as intermediary substances that modulate the immune system's response to HIV rather than directly inhibiting viral replication. This indirect approach through immune enhancement (increasing CD4+ T cells) avoids the selection pressure that leads to tolerant cell line emergence.
Solution Approach 2:
Instead of directly attacking the virus with protease inhibitors, the invention inverts the approach by strengthening the host immune system (particularly CD4+ T cell count) to naturally combat HIV replication. This immune-based approach avoids the resistance issues associated with direct antiviral agents.
3Object-affected harmful factors
If novel medicaments are developed to minimize side effects, then adverse effects are reduced, but therapeutic effectiveness must be maintained
Solution Approach 1:
The invention uses composite plant-based formulations combining multiple plant stem cell lines (Panax ginseng, Panax notoginseng, Angelica sinensis) and their extracts. This composite approach provides synergistic effects that maintain therapeutic effectiveness while reducing side effects, as the multiple natural compounds work together to enhance immune function without the toxicity of single synthetic agents.
Data Source
AI summary
The present invention relates to a composition for preventing or treating acquired immunodeficiency syndrome (AIDS), comprising one or more of the following: a homogenous cell line, and a lysate, an extract and a culture thereof as an active ingredient. The homogenous cell line, the lysate, the extract and the culture thereof, which are derived from a natural product, minimize adverse side effects of prior therapeutic agents and safe for the human body. Further, they effectively increase the count of T cells such as CD4+ T cells and decrease the number of HIVs, thereby preventing opportunistic infection, dysneuria, and neoplaia caused by immune incompetence, and ultimately the risk of death. Therefore, they are useful in preventing and treating AIDS, and relieving symptoms of AIDS.